Jump to main content
Jump to site search

Issue 10, 2018
Previous Article Next Article

Peptide-based nanoprobes for molecular imaging and disease diagnostics

Author affiliations


Pathological changes in a diseased site are often accompanied by abnormal activities of various biomolecules in and around the involved cells. Identifying the location and expression levels of these biomolecules could enable early-stage diagnosis of the related disease, the design of an appropriate treatment strategy, and the accurate assessment of the treatment outcomes. Over the past two decades, a great diversity of peptide-based nanoprobes (PBNs) have been developed, aiming to improve the in vitro and in vivo performances of water-soluble molecular probes through engineering of their primary chemical structures as well as the physicochemical properties of their resultant assemblies. In this review, we introduce strategies and approaches adopted for the identification of functional peptides in the context of molecular imaging and disease diagnostics, and then focus our discussion on the design and construction of PBNs capable of navigating through physiological barriers for targeted delivery and improved specificity and sensitivity in recognizing target biomolecules. We highlight the biological and structural roles that low-molecular-weight peptides play in PBN design and provide our perspectives on the future development of PBNs for clinical translation.

Graphical abstract: Peptide-based nanoprobes for molecular imaging and disease diagnostics

Back to tab navigation

Publication details

The article was received on 16 Nov 2017 and first published on 02 Mar 2018

Article type: Review Article
DOI: 10.1039/C7CS00793K
Citation: Chem. Soc. Rev., 2018,47, 3490-3529
  •   Request permissions

    Peptide-based nanoprobes for molecular imaging and disease diagnostics

    P. Zhang, Y. Cui, C. F. Anderson, C. Zhang, Y. Li, R. Wang and H. Cui, Chem. Soc. Rev., 2018, 47, 3490
    DOI: 10.1039/C7CS00793K

Search articles by author